TARRYTOWN, N.Y., Aug. 3, 2018 /PRNewswire/ --
Both young scientists are pursuing important research to further the understanding and treatment of neurological conditions
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the winners of the sixth annual Regeneron Prize for Creative Innovation, an award designed to recognize, reward and foster talented early-career biomedical scientists. The
"The Regeneron Prize for Creative Innovation seeks to honor determined, creative young scientists who are leading the way for the next generation of medical breakthroughs," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron. "This year's accomplished winners are working in mental health and neurological disorders; critical areas of research with a profound need for better therapeutic interventions. We hope they will serve as inspiration to other potential young scientists who have ideas that can improve our world."
Competitors were reviewed by a selection committee of senior scientists at Regeneron. In May 2018, finalists visited Regeneron to tour the campus and present their 'dream' research proposals in biomedical research, which offered insight into each nominee's creativity and ability to think independently as scientists.
The two winners will each receive a $50,000 cash prize, and Harvard Medical School will receive a donation to support its seminar series. This year's winners are:
"For six years now, the Regeneron Prize has elicited submissions from the brightest young minds in science on their dream projects," said Susan Croll, Ph.D., Regeneron scientist and Director of the Regeneron Postdoctoral Training Program. "This year's winners once again demonstrate the vast potential of the coming generation of scientists. We congratulate these outstanding scientists on their accomplishments and are eager to see what other feats they personally achieve and inspire in others."
Requests for applications are distributed to academic institutions late each fall. Institutions are asked to nominate two graduate students and two postdoctoral fellows. In addition to the dream project proposals, submissions must include a curriculum vitae and a sample of publications that enable the selection committee to review each nominee's scholarly productivity.
About Regeneron Pharmaceuticals, Inc.Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, Regeneron's science-driven approach has resulted in six FDA-approved medicines and numerous product candidates, all of which are homegrown in their laboratories. Regeneron's medicines and pipeline are designed to help in a range of diseases, including eye disease, allergic and inflammatory diseases, cancer, pain, infectious diseases and rare diseases. We believe that scientists should be the world's heroes and are committed to fostering the next generation of scientific talent through STEM (Science, Technology, Engineering, Math) education efforts. For additional information about the company, please visit www.regeneron.com or follow Regeneron on Twitter and Facebook.
Regeneron Media RelationsAlexandra BowieTel: +1 (202) firstname.lastname@example.org
1 Orefice, L.L. (2016). "Peripheral Mechanosensory Neuron Dysfunction Underlies Tactile and Behavioral Deficits in Mouse Models of ASDs." Cell, 166, 299-313.2 Starkweather, C.K. (2017). "Dopamine reward prediction errors reflect hidden-state inference across time." Nature Neuroscience, 20(4), 581-589.
View original content:http://www.prnewswire.com/news-releases/regeneron-announces-the-2018-winners-of-the-regeneron-prize-for-creative-innovation-300691416.html
SOURCE Regeneron Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Graviola''s health benefits range from curing headaches to fighting cancer. Read on to know more ...
Gene therapy is a specialized procedure where genetic material is introduced into the cells of a ...
The orange-like citrus fruit, Kumquat, is a complete health booster if included regularly in your ...View All